Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Autolus Therapeutics plc (AUTL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 6-K Quarterly results
Docs: "6-K",
"INDEX TO CONDENSED CONSOLIDATED FINANCIAL",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
"Autolus Therapeutics Reports Second Quarter 2023 Financial Results and Operational Progress"
07/21/2023 6-K Quarterly results
07/10/2023 SC 13G Paradigm Biocapital Advisors LP reports a 5.8% stake in Autolus Therapeutics plc
07/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
05/04/2023 6-K Quarterly results
03/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/07/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/01/2023 F-6EF Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
02/14/2023 SC 13G/A Nantahala Capital Management, LLC reports a 4.7% stake in Autolus Therapeutics plc
02/14/2023 SC 13G/A Frazier Life Sciences Public Fund, L.P. reports a 2.2% stake in Autolus Therapeutics plc
02/14/2023 SC 13G ARMISTICE CAPITAL, LLC reports a 5.9% stake in Autolus Therapeutics, plc
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Dr. Christian Itin, Chief Executive Officer of Autolus."
12/21/2022 6-K Quarterly results
12/19/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/13/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/13/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/09/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Underwriting Agreement, among the Company and Jefferies LLC, William Blair & Company, L.L.C. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein",
"Opinion of Cooley (UK) LLP, counsel to the Company",
"Autolus Announces Pricing of Public Offering"
12/09/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/08/2022 6-K Quarterly results
12/08/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/21/2022 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
11/03/2022 6-K Quarterly results
10/05/2022 SC 13D/A PPF Capital Partners Fund B.V. reports a 16.1% stake in AUTOLUS THERAPEUTICS PLC
08/04/2022 6-K Quarterly results
07/01/2022 6-K Quarterly results
06/01/2022 6-K Quarterly results
05/18/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/18/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/03/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/29/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy